Silent Lungs, Loud Kidneys: Renal Sarcoidosis

Introduction: Renal sarcoidosis is rare, often occurring with extrarenal disease. Its true incidence is unknown, though autopsies reveal granulomatous interstitial nephritis in up to 23% of sarcoidosis cases. We report a case of biopsy-proven renal sarcoidosis in a patient with stable lung imaging but declining renal function. Case Description: 71 yo woman with stable mediastinal lymphadenopathy and weight loss was referred for AKI (Cr 0.8→1.8mg/dL over 8 months). Workup showed mild proteinuria, hypercalcemia, anemia, elevated 1,25-vit D, and inflammatory markers. Without pulmonary progression to justify treatment, she underwent a renal biopsy, which revealed granulomatous tubulointerstitial nephritis and nephrocalcinosis, consistent with sarcoidosis. She was started on prednisone 40mg daily with improved Cr to 1.0 at 12 wks, and normalization of calcium levels, hemoglobin, and CRP. Discussion: Renal sarcoidosis is rare, especially without other organ involvement. As such, requiring a kidney biopsy to change management is uncommon. Classic findings include granulomatous interstitial nephritis, but non-granulomatous interstitial nephritis and nephrocalcinosis can also occur. Biopsy can aid with prognosis, as the extent of fibrosis may predict steroid response. Early treatment with steroids (0.5-1mg/kg/day) is key to preventing ESKD, but no formal guidelines exist. Our patient responded to an initial dose of 0.7mg/kg prednisone, with renal function improving near baseline in 12 weeks. However, with relapse rates of 30-40%, long-term management remains a challenge needing further research.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025qmawf1hc
Primary Topic
Sarcoidosis and Beryllium Toxicity Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Silent Lungs, Loud Kidneys: Renal Sarcoidosis

Amanda Abi Doumet, William Ackley, Harold Yamase
Journal of the American Society of Nephrology
Sarcoidosis and Beryllium Toxicity Research
article

Silent Lungs, Loud Kidneys: Renal Sarcoidosis

Amanda Abi Doumet, William Ackley, Harold Yamase
article en

Abstract

Introduction: Renal sarcoidosis is rare, often occurring with extrarenal disease. Its true incidence is unknown, though autopsies reveal granulomatous interstitial nephritis in up to 23% of sarcoidosis cases. We report a case of biopsy-proven renal sarcoidosis in a patient with stable lung imaging but declining renal function. Case Description: 71 yo woman with stable mediastinal lymphadenopathy and weight loss was referred for AKI (Cr 0.8→1.8mg/dL over 8 months). Workup showed mild proteinuria, hypercalcemia, anemia, elevated 1,25-vit D, and inflammatory markers. Without pulmonary progression to justify treatment, she underwent a renal biopsy, which revealed granulomatous tubulointerstitial nephritis and nephrocalcinosis, consistent with sarcoidosis. She was started on prednisone 40mg daily with improved Cr to 1.0 at 12 wks, and normalization of calcium levels, hemoglobin, and CRP. Discussion: Renal sarcoidosis is rare, especially without other organ involvement. As such, requiring a kidney biopsy to change management is uncommon. Classic findings include granulomatous interstitial nephritis, but non-granulomatous interstitial nephritis and nephrocalcinosis can also occur. Biopsy can aid with prognosis, as the extent of fibrosis may predict steroid response. Early treatment with steroids (0.5-1mg/kg/day) is key to preventing ESKD, but no formal guidelines exist. Our patient responded to an initial dose of 0.7mg/kg prednisone, with renal function improving near baseline in 12 weeks. However, with relapse rates of 30-40%, long-term management remains a challenge needing further research.

Journal of the American Society of NephrologyVol. 36(10S)
UConn Health (US)
Openalex Percentile: Top 62%
Sarcoidosis and Beryllium Toxicity Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.